ID | Description | Counts | P Value | qvalue | Category |
---|---|---|---|---|---|
GO:0050867 | positive regulation of cell activation | 45 | 2.39264E-23 | 2.14E-47 | GO_BP |
GO:0002250 | adaptive immune response | 45 | 3.8263E-23 | 1.62E-50 | GO_BP |
GO:0002696 | positive regulation of leukocyte activation | 43 | 9.36341E-23 | 2.56E-44 | GO_BP |
GO:0002443 | leukocyte mediated immunity | 42 | 7.99351E-20 | 5.00E-39 | GO_BP |
GO:0002683 | negative regulation of immune system process | 41 | 1.45064E-17 | 5.98E-48 | GO_BP |
GO:1903131 | mononuclear cell differentiation | 41 | 2.26455E-17 | 1.32E-35 | GO_BP |
GO:0002697 | regulation of immune effector process | 40 | 7.77577E-18 | 4.62E-41 | GO_BP |
GO:0045785 | positive regulation of cell adhesion | 40 | 2.91266E-16 | 3.47E-45 | GO_BP |
GO:0032103 | positive regulation of response to external stimulus | 39 | 3.31556E-16 | 8.34E-33 | GO_BP |
GO:0002253 | activation of immune response | 38 | 1.06302E-21 | 7.46E-31 | GO_BP |
GO:0009897 | external side of plasma membrane | 49 | 1.76287E-27 | 4.45358E-25 | GO_CC |
GO:0031012 | extracellular matrix | 25 | 2.97486E-09 | 1.38221E-07 | GO_CC |
GO:0030312 | external encapsulating structure | 25 | 3.28275E-09 | 1.38221E-07 | GO_CC |
GO:0000323 | lytic vacuole | 20 | 5.42278E-05 | 0.000856229 | GO_CC |
GO:0005764 | lysosome | 20 | 5.42278E-05 | 0.000856229 | GO_CC |
GO:0043235 | receptor complex | 18 | 5.16901E-05 | 0.000856229 | GO_CC |
GO:0062023 | collagen-containing extracellular matrix | 17 | 2.28492E-07 | 6.41381E-06 | GO_CC |
GO:0001772 | immunological synapse | 12 | 1.7685E-12 | 2.2339E-10 | GO_CC |
GO:0005581 | collagen trimer | 12 | 8.66691E-11 | 5.47384E-09 | GO_CC |
GO:0005770 | late endosome | 12 | 0.00057603 | 0.006929687 | GO_CC |
GO:0140375 | immune receptor activity | 18 | 2.17255E-12 | 8.96465E-10 | GO_MF |
GO:0019955 | cytokine binding | 17 | 1.18871E-10 | 1.635E-08 | GO_MF |
GO:0042277 | peptide binding | 16 | 5.03693E-05 | 0.000989713 | GO_MF |
GO:0033218 | amide binding | 16 | 0.000544452 | 0.008640692 | GO_MF |
GO:0030246 | carbohydrate binding | 15 | 1.41925E-05 | 0.000344487 | GO_MF |
GO:0004896 | cytokine receptor activity | 14 | 2.47717E-10 | 2.55539E-08 | GO_MF |
GO:0003823 | antigen binding | 13 | 2.461E-11 | 5.07742E-09 | GO_MF |
GO:0005539 | glycosaminoglycan binding | 12 | 0.000172029 | 0.003086288 | GO_MF |
GO:0008528 | G protein-coupled peptide receptor activity | 11 | 1.90402E-05 | 0.000436477 | GO_MF |
GO:0001653 | peptide receptor activity | 11 | 3.32433E-05 | 0.000685862 | GO_MF |
rno04514 | Cell adhesion molecules | 20 | 1.45E-11 | 1.20E-09 | KEGG |
rno04060 | Cytokine-cytokine receptor interaction | 20 | 1.90E-08 | 2.53E-07 | KEGG |
rno05169 | Epstein-Barr virus infection | 16 | 9.66E-07 | 8.92E-06 | KEGG |
rno05166 | Human T-cell leukemia virus 1 infection | 16 | 3.45E-06 | 2.74E-05 | KEGG |
rno05171 | Coronavirus disease - COVID-19 | 16 | 7.21E-05 | 0.00042816 | KEGG |